(Q39287960)

10 September 2017

Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties (English)

1 reference

10 September 2017

1 reference

R Castoldi

1

1 reference

10 September 2017

U Jucknischke

2

1 reference

10 September 2017

L P Pradel

3

1 reference

10 September 2017

E Arnold

4

1 reference

10 September 2017

C Klein

5

1 reference

10 September 2017

S Scheiblich

6

1 reference

10 September 2017

G Niederfellner

7

1 reference

10 September 2017

C Sustmann

8

1 reference

10 September 2017

language of work or name

1 reference

29 August 2012

1 reference

Protein Engineering Design and Selection

10 September 2017

1 reference

10 September 2017

25

1 reference

10 September 2017

10

1 reference

10 September 2017

551-559

1 reference

A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Bispecific digoxigenin-binding antibodies for targeted payload delivery

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Combining molecular targeted therapies: clinical experience

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancer.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Cancer therapy with bispecific antibodies: Clinical experience.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Alternative antibody formats.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Safety profile of new anticancer drugs.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Bispecific antibodies for cancer therapy: the light at the end of the tunnel?

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Bispecific antibodies for cancer therapy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

ErbB receptors and signaling pathways in cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Antibodies for therapeutic uses and the evolution of biotechniques

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Fcgamma receptors as regulators of immune responses

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

FcRn: the neonatal Fc receptor comes of age.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Antibody engineering and modification technologies

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Kinomics: characterizing the therapeutically validated kinase space.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

ERBB receptors and cancer: the complexity of targeted inhibitors

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Untangling the ErbB signalling network

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3449402

'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization

10 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22936109

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/PROTEIN/GZS048

1 reference

release_t6kzh7tfubgd3czgzcetwdzga4

10 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t6kzh7tfubgd3czgzcetwdzga4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

10 September 2017

1 reference